SCHEMBL15977893

SCHEMBL15977893

c1ccc(-c2ccc3c(-c4ccc5ccccc5c4)c4ccccc4c(-c4ccc(-c5cc6cccnc6c6ncccc56)cc4)c3c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 4/20 0.40
CCR8 P51685 4/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
CYP11B1 P15538 2/20 0.40
CYP17A1 P05093 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP11B2 P19099 1/20 0.40
TOP1 P11387 3/20 0.38
ESR1 P03372 3/20 0.36
ESR2 Q92731 3/20 0.36
ALDH1A1 P00352 2/20 0.36
CCR5 P51681 2/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 2/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
PIK3CA P42336 1/20 0.35
GPR84 Q9NQS5 1/20 0.35
HTR2B P41595 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12577988 0.93 CYP11B1 (0.40) CCR1CCR8CYP11B1CYP17A1CYP19A1
SCHEMBL16558125 0.91 CCR1 (0.44) CCR1CCR8L3MBTL1CYP11B1TOP1
SCHEMBL16433771 0.91 CCR1 (0.44) CCR1CCR8L3MBTL1CYP11B1CYP17A1
SCHEMBL12577937 0.91 GPR84 (0.40) CCR1CCR8L3MBTL1CYP11B1CYP17A1
SCHEMBL12577950 0.90 CYP11B1 (0.38) CCR1CCR8L3MBTL1CYP11B1CYP17A1
SCHEMBL13820639 0.90 CCR1 (0.37) CCR1CCR8L3MBTL1CYP11B1CYP17A1
SCHEMBL13820713 0.90 CCR1 (0.37) CCR1CCR8L3MBTL1CYP11B1CYP17A1
SCHEMBL10300884 0.89 CCR1 (0.46) CCR1CCR8L3MBTL1CYP11B1TOP1
SCHEMBL12708785 0.88 CCR1 (0.42) CCR1CCR8L3MBTL1CYP11B1CYP17A1
SCHEMBL12577921 0.88 CYP11B1 (0.40) CCR1CCR8L3MBTL1CYP11B1CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 CCR1 304/4885CCR8 1231/4885L3MBTL1 1876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.